Bi-Weekly Paclitaxel - Gemcitabine in Small Cell Lung Cancer Patients Pretreated with Platinum-Etoposide Chemotherapy

被引：0

作者：

Carrera Revilla, Sergio ^{[1
]}

Lopez Vivanco, Guillermo ^{[1
]}

Munoz Llarena, Alberto ^{[1
]}

Rubio Etxcbarria, Itziar ^{[1
]}

Sancho Gutierrez, Aintzane ^{[1
]}

Marrodan Ciordia, Ines ^{[1
]}

Manuel Mane, Juan ^{[1
]}

Ruiz De Lobera, Abigail ^{[1
]}

Ballesteros, David ^{[1
]}

Gutierrez, Eddy ^{[1
]}

机构：

[1] Cruces Hosp, Dept Med Oncol, Baracaldo, Spain

来源：

JOURNAL OF THORACIC ONCOLOGY | 2010年 / 5卷 / 12期

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：S416 / S417

页数：2

共 50 条

[21] Phase II Study of a Bi-Weekly Chemotherapy Regimen of Combined Liposomal Paclitaxel and Nedaplatin for the Treatment of Advanced Squamous Cell Lung Cancer [J].

Lv, Wei-Ze ;

Lin, Zhong ;

Wang, Si-Yang ;

Lv, Bao-Jun ;

Wang, Zhi-Hui ;

Xiao, Mei ;

Xu, Xiao-Lu ;

Peng, Pei-Jian .

TRANSLATIONAL ONCOLOGY, 2019, 12 (04) :656-660

[22] Durvalumab plus platinum-etoposide chemotherapy for extensive-stage small cell lung cancer: a retrospective real-world study [J].

Misawa, Kazuhito ;

Watanabe, Kageaki ;

Seike, Masahiro ;

Hosomi, Yukio .

TRANSLATIONAL LUNG CANCER RESEARCH, 2024, 13 (07) :1585-1594

[23] Bi-weekly administration of gemcitabine plus vinorelbine in elderly patients with advanced non-small-cell lung cancer: Multicenter phase II trial [J].

Araya, Tomoyuki ;

Kasahara, Kazuo ;

Kimura, Hideharu ;

Shibata, Kazuhiko ;

Kita, Toshiyuki ;

Shirasaki, Hiroki ;

Hara, Johsuke ;

Yoshimi, Yuzo ;

Sone, Takashi ;

Oribe, Yoshitaka ;

Nobata, Kouichi ;

Nishi, Kouichi ;

Fujimura, Masaki ;

Nakao, Shinji .

LUNG CANCER, 2007, 56 (03) :371-376

[24] A phase I–II study of bi-weekly gemcitabine and irinotecan as second-line chemotherapy in non-small cell lung cancer after prior taxane + platinum-based regimens [J].

Christos Kosmas ;

Nicolas Tsavaris ;

Konstantinos Syrigos ;

Angelos Koutras ;

George Tsakonas ;

Thomas Makatsoris ;

Nicolas Mylonakis ;

Athanasios Karabelis ;

George P. Stathopoulos ;

Haralambos P. Kalofonos .

Cancer Chemotherapy and Pharmacology, 2007, 59 :51-59

[25] Determining the utilization and clinical impact of platinum-etoposide for treatment of small cell lung cancer in the routine setting [J].

Dimitriou, K. ;

Bozorgmehr, F. ;

Liersch, S. ;

Elshafie, R. ;

Kuon, J. ;

Dinges, L-A. ;

Eichkorn, T. ;

Heussel, C-P. ;

Eichhorn, F. ;

Winter, H. ;

Schneider, M. ;

Herth, F. ;

Steins, M. ;

Stenzinger, A. ;

Thomas, M. ;

Christopoulos, P. .

JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (04) :S725-S725

[26] Cisplatin-Ifosfamide-Gemcitabine as Salvage Chemotherapy in Ovarian Cancer Patients Pretreated with Platinum Compounds and Paclitaxel [J].

Polyzos, Aristides ;

Tsavaris, Nikolas ;

Gogas, Helen ;

Lagadas, Antonios ;

Polyzos, Kostas ;

Giannakopoulos, Kostas ;

Felekouras, Evangelos ;

Tsigris, Christos ;

Karatzas, Theodoros ;

Papadopoulos, Othon ;

Giannopoulos, Athanasios .

ANTICANCER RESEARCH, 2009, 29 (07) :2681-2686

[27] Maintenance chemotherapy with gemcitabine in patients pretreated with induction chemotherapy with cisplatin and gemcitabine for advanced non small cell lung cancer (A-NSCLC) [J].

Papi, Maximilian ;

Nicoletti, Stefania ;

Tassinari, Davide ;

Tamburini, Emiliano ;

Oliverio, Giovanni ;

Agli, Luigi Lazzari ;

Grani, Giorgio ;

Salvi, Maurizio ;

Pasquini, Enzo ;

Ravaioli, Alberto .

ANNALS OF ONCOLOGY, 2007, 18 :32-32

[28] First-Line Durvalumab Plus Platinum-Etoposide Versus Platinum-Etoposide for Extensive-Stage Small-Cell Lung Cancer: A Cost-Effectiveness Analysis [J].

Zhang, Longfeng ;

Hang, Yongfu ;

Liu, Maobai ;

Li, Na ;

Cai, Hongfu .

FRONTIERS IN ONCOLOGY, 2020, 10

[29] A dose and schedule finding study of gemcitabine and etoposide in patients with progressive non-small cell lung cancer after platinum containing chemotherapy [J].

Biesma, B ;

Smit, EF ;

Postmus, PE .

LUNG CANCER, 1999, 24 (02) :115-121

[30] Bi-weekly administration of docetaxel and gemcitabine as first-line therapy for non-small cell lung cancer: A phase II study [J].

Syrigos, KN ;

Dannos, I ;

Dionellis, G ;

Bofos, I ;

Alamara, C ;

Dimakou, E ;

Stratakos, G ;

Papiris, S .

ANTICANCER RESEARCH, 2005, 25 (05) :3489-3493

← 1 2 3 4 5 →